Walkman Use Brings Old Memories Back

Various models of Sony Walkman audio players are displayed at an exhibition marking the 40th anniversary of the iconic device, in Tokyo on July 10. BEHROUZ MEHRI/AFP
Various models of Sony Walkman audio players are displayed at an exhibition marking the 40th anniversary of the iconic device, in Tokyo on July 10. BEHROUZ MEHRI/AFP
TT

Walkman Use Brings Old Memories Back

Various models of Sony Walkman audio players are displayed at an exhibition marking the 40th anniversary of the iconic device, in Tokyo on July 10. BEHROUZ MEHRI/AFP
Various models of Sony Walkman audio players are displayed at an exhibition marking the 40th anniversary of the iconic device, in Tokyo on July 10. BEHROUZ MEHRI/AFP

In 1989, jewelry maker Tiffany & Co and electronics company Sony released a silver-plated Walkman (complete with a fitted wooden box) to celebrate 10 years of the portable cassette player. Only 250 were made at the time, according to The Guardian.

Several decades on, and long since the cassette Walkman began its slide into obsolescence – outpaced first by the cumbersome Discman and the vibe-less MiniDisc player, then lapped by the iPod and iPhone – you can still find some of these items selling in auctions for hundreds and sometimes thousands of pounds.

One of the Tiffany Walkmans, originally presented to the Who, was later sold by the ex-wife of the band’s late bassist John Entwistle on a 2011 episode of the US TV show Pawn Stars. After some haggling, the traders at Gold & Silver Pawn in Las Vegas agreed to pay $1,250 for it.

“This is one of those weird things that I think someone’s willing to buy just to say they have it,” Pawn Stars’ Corey Harrison said.

But who would spend thousands on a tape player in the age of Spotify and YouTube, when virtually all your entertainment needs can be concentrated into one device in your pocket? “Time can make easy fetishists of us all,” remarked the culture writer Niko Stratis on seeing news stories reporting that branches of Urban Outfitters in the US were selling iPods for $350 (not far off the price they were on release in the early 2000s). There is plenty of such backward-gazing trading to be found online: eBay seller Retrogadgets-UK offers a “factory-sealed” third-generation iPhone “sold for collectors only” listed at £2,499.99.”

US brand Retrospekt sells all manner of refurbished old tech. “Our mission is to give you a product with years of history that works like it was made yesterday,” it declares.

Elsewhere you can find camcorders and digital cameras, VHS and DVD players, “vintage” Game Boys and everything, including the soundtrack to classic teen soap Beverly Hills on cassette (yours for £15.39) and a surprisingly large number of Walkmans.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”